Results 201 to 210 of about 211,728 (287)

Conversion Therapy for cT4b and M1 Esophageal Squamous Cell Carcinoma: A Comprehensive Systematic Review

Annals of Gastroenterological Surgery, EarlyView.
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley   +1 more source

Medical damage liability risk of medical AI: from the perspective of DeepSeek's large-scale deployment in Chinese hospitals. [PDF]

Front Public Health
Wang Y, Zhou Z.
europepmc   +1 more source

Time‐Dependent Recovery of Gastric Emptying After Gastrectomy: A 12‐Month Longitudinal Study Using a 13C‐Acetate Breath Test With a Semi‐Solid Meal

Annals of Gastroenterological Surgery, EarlyView.
This study examined time‐dependent changes in gastric emptying after gastrectomy for gastric cancer using a 13C‐acetate breath test with a semi‐solid meal in 95 patients, revealing that gastric emptying was initially delayed at 1 month but significantly accelerated by 12 months postoperatively.
Sachiko Kaida, Katsushi Takebayashi, Mika Kurihara, Reiko Otake, Haruki Mori, Hiromitsu Maehira, Toru Miyake, Shigeki Bamba, Masaji Tani   +8 more
wiley   +1 more source

The Influence of Surgeons' Gender on Surgical Outcomes in Laparoscopic Right Hemicolectomy: A Japanese Nationwide Retrospective Cohort Study

Annals of Gastroenterological Surgery, EarlyView.
This study analyzed 58 503 laparoscopic right hemicolectomies for colon cancer in Japan between 2018 and 2022, comparing outcomes between male and female surgeons. No significant differences were found in surgical mortality or severe complications. Tailored surgical training programs for female surgeons may further enhance surgical outcomes.
Akihisa Matsuda, Hideki Endo, Aya Yamagishi, Hiroyuki Yamamoto, Shuji Takiguchi, Koki Otsuka, Takeshi Yamada, Hiroshi Yoshida, Hideki Ueno, Yuko Kitagawa, Ken Shirabe   +10 more
wiley   +1 more source

Analysing similarities between legal court documents using natural language processing approaches based on transformers. [PDF]

PLoS One
Oliveira RS, Sperandio Nascimento EG.
europepmc   +1 more source

JPE 2.0: A Modern Approach to Evaluating Judicial Performance

Jordan M. Singer, Danielle Kalil
openalex   +1 more source

Influence of Hospital and Surgeon Volumes on Clinical Outcomes After Standard Surgery for Advanced Gastric Cancer: Supplementary Analysis of the Multicenter Randomized Phase III Trial JCOG1001

Annals of Gastroenterological Surgery, EarlyView.
We have evaluated interinstitutional variation to verify the generalization and standardization of gastric cancer surgery from a supplementary analysis of the randomized phase III trial JCOG1001. Although there was some degree of interinstitutional variation in short‐ and long‐term outcomes after standard gastric surgery, we found no correlation ...
Motohiro Hirao, Yukinori Kurokawa, Riku Kajikawa, Junki Mizusawa, Kota Kawabata, Masanori Tokunaga, Kenji Kuroda, Shinichi Sakuramoto, Itaru Yasufuku, Hisayuki Matsushita, Shuji Takiguchi, Yuichiro Doki, Takaki Yoshikawa, Masanori Terashima, Stomach Cancer Study Group of Japan Clinical Oncology Group   +14 more
wiley   +1 more source

LegalEye: Multimodal Court Deception Detection Across Multiple Languages. [PDF]

Behav Sci (Basel)
Baldivas RIA, Sreenivasan N, Kang SY, Miller AM, Chacko M, Krishnan S, Ayala C, Ayala E, Kim D.   +8 more
europepmc   +1 more source

Judicial and Administrative Review of Government Contract Awards [PDF]

, 1972
Speidel, Richard E.
core   +2 more sources

Total Neoadjuvant Therapy for Rectal Cancer: Why Japan Says “Not Yet”

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Total neoadjuvant therapy (TNT) has rapidly gained global acceptance as a standard treatment for locally advanced rectal cancer (LARC). Supported by multiple phase III trials, TNT improves pathological complete response (pCR) rates, enhances systemic control, and expands opportunities for non‐operative management (NOM).
Kay Uehara, Akihisa Matsuda, Takeshi Yamada, Aitsariya Monkhonsupphawan, Hiroshi Yoshida   +4 more
wiley   +1 more source